#USA #Chicago #Bridge to Life #VitaSmart™ #Castiglioni

Bridge to Life Appoints David Castiglioni as CCO

Bridge to Life Ltd., a frontrunner in organ preservation solutions and perfusion technology, has made a significant leadership announcement. The company has appointed David Castiglioni as its new Chief Commercial Officer (CCO). This strategic move aims to enhance its global commercial operations, particularly in anticipation of the U.S. launch of the innovative VitaSmart™ Hypothermic Oxygenated Perfusion System, which is pending FDA clearance. The introduction of this system is crucial as the U.S. stands as the largest market worldwide for machine perfusion technology.

A Proven Leader in Healthcare and Medtech

David Castiglioni brings an impressive nearly thirty years of leadership experience within the healthcare, medtech, and biotechnology sectors. His tenure at leading companies showcases a consistent record of success in developing high-performing commercial teams and driving significant growth in early-stage ventures. Notably, during his time at Intuitive Surgical, he was instrumental in the adoption of their da Vinci surgical system, contributing to the company’s establishment as a key player in the medtech landscape.

Following his impactful role at Intuitive Surgical, Castiglioni held the position of CCO at various organizations, including Hyperfine, MediGO (which was acquired by CareDx), and Siren Care. In each of these roles, he successfully implemented go-to-market strategies that resulted in rapid revenue growth across multiple regions including the U.S., Europe, and Asia-Pacific.

Looking Ahead with Excitement

On his new role, Castiglioni expressed enthusiasm about joining Bridge to Life, emphasizing the VitaSmart™ system’s proven success in Europe and the immense potential it holds for the U.S. market. “The upcoming U.S. launch represents a pivotal opportunity to bring this innovation to the world's largest transplant market,” he stated. This innovative system is anticipated to significantly impact the transplant ecosystem within the United States, and Castiglioni’s leadership will be pivotal in realizing this potential.

Company Goals and Vision

Don Webber, President and CEO of Bridge to Life, expressed optimism regarding Castiglioni's appointment, emphasizing the critical moment for the organization as it prepares for the launch of VitaSmart™. Webber highlighted Castiglioni’s ability to create world-class commercial organizations and his experience in delivering quality product offerings, reinforcing that he is the ideal fit for leading this initiative.

Bridge to Life positions itself as a leader in organ preservation solutions, known for its high-quality products such as Belzer UW®, EasiSlush®, and the upcoming VitaSmart™ Hypothermic Oxygenated Perfusion System. The company maintains a strong commitment to innovation, product quality, and accessibility, working closely with Transplant Centers and Organ Procurement Organizations globally.

Conclusion

As Bridge to Life continues its trajectory of growth and innovation under Castiglioni’s stewardship, the company's commitment to enhancing transplant solutions is clearer than ever. With VitaSmart™ poised for the U.S. market, the upcoming launch is set to transform organ preservation and transplant procedures, benefiting countless lives in the process. As the healthcare industry evolves, Bridge to Life stands at the forefront, ready to lead with groundbreaking solutions and strong leadership.